Skip to main content
logo
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.230
-0.110 (-8.21%)
At close: Aug 8, 2025, 4:00 PM
1.290
+0.060 (4.88%)
After-hours: Aug 8, 2025, 7:59 PM EDT

Company Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening viral infectious, diseases in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
CountryUnited States
Founded1984
IndustryMedical Devices
SectorHealthcare
Employees9
CEOJames Frakes

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone619 941 0360
Websiteaethlonmedical.com

Stock Details

Ticker SymbolAEMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0000882291
CUSIP Number00808Y307
ISIN NumberUS00808Y4061
Employer ID13-3632859
SIC Code3841

Key Executives

NamePosition
James B. Frakes M.B.A.Chief Executive Officer, Chief Financial Officer, Secretary and Director
Guy F. Cipriani BS (Eng.), MBASenior Vice President and Chief Operating Officer
Dr. Steven P. LaRosa M.D.Chief Medical Officer
Michele BombardiereVice President and Controller

Latest SEC Filings

DateTypeTitle
Jun 27, 20258-KCurrent Report
Jun 26, 202510-KAnnual Report
Jun 5, 20258-KCurrent Report
May 15, 2025SCHEDULE 13GFiling
May 13, 20258-KCurrent Report
Apr 18, 2025DEF 14AOther definitive proxy statements
Apr 8, 2025PRE 14AOther preliminary proxy statements
Mar 17, 20258-KCurrent Report
Feb 14, 2025SCHEDULE 13GFiling
Feb 12, 202510-QQuarterly Report
View All SEC Filings